Track Lannett , Inc.'s common stock ($11K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (March 2023), LCI shows a common stock of $11K. That compares with $41M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, LCI's common stock is now $11K (was $41M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lannett , Inc. is outperforming or lagging.
Tracking LCI's common stock over time shows whether Lannett , Inc. is scaling, shrinking, or reshaping that part of the business. The current reading is $11K That compares with $41M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Lannett , Inc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $11K) with ownership activity and broader fundamentals.
Lannett , Inc.'s common stock is $11K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.